IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Free cash flow 2016–2025
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$336.2MFY2025 · since FY2016: -$34.2M → -$336.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$336.2M | +7.6% |
| FY2024 | -$364.0M | +5.2% |
| FY2023 | -$384.1M | -22.6% |
| FY2022 | -$313.2M | -18.0% |
| FY2021 | -$265.5M | -5.4% |
| FY2020 | -$251.9M | -51.9% |
| FY2019 | -$165.8M | -61.8% |
| FY2018 | -$102.4M | -28.5% |
| FY2017 | -$79.7M | -133.2% |
| FY2016 | -$34.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More IOVA financial trends
IOVA RevenueIOVA Net incomeIOVA Net marginIOVA Gross profitIOVA Gross marginIOVA Operating incomeIOVA Operating marginIOVA Operating cash flowIOVA Capital expendituresIOVA Return on equityIOVA Stock buybacksIOVA Dividends paidIOVA Total assetsIOVA Total liabilitiesIOVA Shareholders’ equityIOVA overview →